Sensor Controls Pump, Motor, Or Pressure Driven Means Patents (Class 604/67)
  • Patent number: 11511099
    Abstract: An apparatus is provided for detecting mating of a cap with a fluid delivery device having a housing, a receptacle, and a sensor. The housing is configured to carry an insulin delivery device having a reservoir of the fluid. The receptacle is provided by the housing having a coupling with a locking recess configured to receive a cap with a sprung locking arm. The pressure sensor is carried by the receptacle proximate the coupling and configured to detect engagement force of the sprung locking arm with the receptacle when mated with the housing. A method is also provided.
    Type: Grant
    Filed: October 8, 2019
    Date of Patent: November 29, 2022
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Amith Wijesuriya, Thomas P. Miller
  • Patent number: 11497850
    Abstract: A medical device includes a first housing portion (FHP) and a second housing portion (SHP) configured to be to be movable relative to each other from a first position to operatively engage at a second position to couple at least one of a drive device and a needle-inserting device supported by one of the FHP and the SHP to a reservoir supported by the other of the FHP and the SHP. Electronic circuitry configured to detect at least one of a first magnetic interaction between a magnet and at least one of a first magnetically attractive material and a first magnet-responsive device and a second magnetic interaction between the magnet and at least one of a second magnetically attractive material and a second magnet-responsive device, and to provide a signal or a change in state in response to detecting at least one of the interactions.
    Type: Grant
    Filed: May 31, 2019
    Date of Patent: November 15, 2022
    Assignee: MEDTRONIC MINIMED, INC.
    Inventors: Ian B. Hanson, Paul F. Bente, IV
  • Patent number: 11464906
    Abstract: Some embodiments of an infusion pump system may be configured to allow the user to communicate with the infusion pump system using voice or image input. Optionally, particular embodiments can interpret the voice or image input using speech or image recognition capabilities. By incorporating speech or image recognition equipment within the infusion pump system, user interactions with the pump system can be enhanced and simplified.
    Type: Grant
    Filed: January 15, 2020
    Date of Patent: October 11, 2022
    Assignee: Bigfoot Biomedical, Inc.
    Inventor: Mark C. Estes
  • Patent number: 11458246
    Abstract: Disclosed herein are systems and methods for monitoring performance of an ambulatory infusion pump. An ambulatory infusion pump can include a reservoir configured to contain a medicament including a plunger at a proximal end of the reservoir and an outlet port at a distal end of the reservoir. A motor can be configured to cause linear motion of a pushrod to contact and move the plunger to cause medicament to flow from the reservoir out of the outlet port to a patient. An optical encoder can be employed to monitor a linear position of the pushrod. In addition, the optical encoder can be employed to monitor additional system conditions and/or a secondary encoder can be employed to monitor the performance of the optical encoder.
    Type: Grant
    Filed: February 4, 2019
    Date of Patent: October 4, 2022
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Alexander Seitz, Michael Michaud, Philip Sven Lamb, Justin Brown, Geoffrey A. Kruse
  • Patent number: 11446431
    Abstract: A peristaltic infusion pump system has a convex platen surface opposite a linear peristaltic pumping mechanism. The convex platen surface may be part of a cassette of an administration set removably loadable in an infusion pump, or the convex platen surface may be a feature of the pump itself. Pumping efficiency is improved without giving up the ability to have independently controlled compensating fingers. The convex platen surface may have a trapezoidal profile, a curved profile, or a hybrid profile having upstream and downstream inclined portions connected by an intermediate curved portion.
    Type: Grant
    Filed: November 14, 2019
    Date of Patent: September 20, 2022
    Assignee: ZEVEX, INC.
    Inventors: Azur Azapagic, Kent F. Beck, J. Ryan Stanfield
  • Patent number: 11439753
    Abstract: An apparatus for regulating the concentration of glucose in the blood of a person includes: at least one glucose sensor that is arranged to measure the glucose concentration of the person, for example in the interstitial fluid or blood; a pump for selectively introducing at least one substance influencing the blood glucose levels into the body of the person, for instance by at least one cannula or catheter to be inserted into the body of said person, and a control for controlling said at least one substance influencing the blood glucose levels to be introduced to the person based on data received from said glucose sensor. Said apparatus includes at least one further sensor that is arranged to monitor a further characteristic of the person. The at least one further sensor may include an accelerometer, a heart rate sensor, a temperature sensor, a pH sensor, a ketone sensor, a GPS receiver, and/or a skin resistance sensor.
    Type: Grant
    Filed: November 29, 2017
    Date of Patent: September 13, 2022
    Assignee: Inreda Diabetic B.V.
    Inventors: Robin Koops, Gijs Benno Westen
  • Patent number: 11433182
    Abstract: A drug delivery device comprises first and second liquid drug reservoirs and first and second outlet ports. A drive is configured for expelling a first liquid drug from the first reservoir to the first outlet port and for expelling a second liquid drug from the second reservoir to the second outlet port. A memory is provided that contains a drug dosing scheme specifying a desired liquid drug type, and at least one sensor is provided that detects information concerning the type of liquid drug contained in the first and/or second reservoir. A processor receives the information from the at least one sensor and thereby determines the type of liquid drug retained in the first reservoir and/or the second reservoir, and uses the drug dosing scheme and the determined type of liquid drug to operate the drive. Associated devices this disclosure and methods are also disclosed.
    Type: Grant
    Filed: May 24, 2019
    Date of Patent: September 6, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Frank Deck, Hans List
  • Patent number: 11430558
    Abstract: A method, system, and computer program product for peer exchange of data between injection systems. A first injection system may store a plurality of injection control data sets, determine a first subset of the plurality of injection control data sets according to which the first injection system is configured to control delivery of fluid to a patient, provide the first subset of the plurality of injection control data sets for selection of an injection control data set for use in delivering fluid to the patient with the first injection system, and transmit the plurality of injection control data sets to at least one second injection system.
    Type: Grant
    Filed: July 3, 2018
    Date of Patent: August 30, 2022
    Assignee: BAYER HEALTHCARE LLC
    Inventors: John Volkar, Corey Kemper, Srikanth Mruthik, Michael Oklejewski
  • Patent number: 11426567
    Abstract: Embodiments herein relate to an implantable device comprising a casing, a semi-permeable membrane plug at or near a first end of the casing, a piston, beads, and an opening for release of the beads from the implantable device within a body of a human or an animal; wherein the implantable device is configured to be implanted within the body of the human or the animal during delivery of the beads into the body of the human or the animal; wherein the beads comprise a core and a shell with the core being enclosed by the shell and the beads contain a drug; and wherein the implantable device is configured to produce a desired flow rate of elution of the drug from the implantable device when the implantable device is implanted within the body of the human or the animal.
    Type: Grant
    Filed: July 29, 2019
    Date of Patent: August 30, 2022
    Inventor: Neil S. Davey
  • Patent number: 11415095
    Abstract: A fuel injection valve includes a nozzle portion for injecting fuel, a fuel inlet port, a fuel supply main passage for supplying the fuel from the fuel inlet port to the nozzle portion, a pressure sensor for detecting fuel pressure in the fuel supply main passage, and a fuel introduce passage for supplying the fuel from the fuel supply main passage to the pressure sensor. The fuel supply main passage includes a first fuel supply passage extending in a first direction from the fuel inlet port to the pressure sensor and a second fuel supply passage extending in a second direction from the pressure sensor to the nozzle portion.
    Type: Grant
    Filed: August 4, 2020
    Date of Patent: August 16, 2022
    Assignee: DENSO CORPORATION
    Inventors: Atsushi Kondou, Tomonori Kamiya, Yoshinori Okuno
  • Patent number: 11406320
    Abstract: Methods and apparatus for guiding medical care based on sensor data from the gastrointestinal tract are described utilizing an apparatus which can be used with enteral feeding. Generally, the apparatus includes an elongated body having a length configured for insertion into a stomach and at least one pair of electrodes located along the length of the elongated body and positionable for placement within the stomach. A controller in electrical communication with the at least one pair of electrodes is included and the control may also be configured to measure a conductivity or impedance between the pair of electrodes and to determine a gastric residual volume of the stomach based on the measured conductivity or impedance.
    Type: Grant
    Filed: November 13, 2017
    Date of Patent: August 9, 2022
    Assignee: Gravitas Medical, Inc.
    Inventors: Saheel Sutaria, Eliott Bennett-Guerrero, Braden Eliason, Arthur Spivy, Daniel R. Burnett
  • Patent number: 11406753
    Abstract: A repeater system may control a pump by using a repeater and a user interface. An adhesive patch system may be used for affixing a pump or other object to a human body. Such an adhesive patch system may include two sets of adhesive members, each member including an adhesive material on at least one side so as to attach to the body. The members of the first set are spaced to allow the members of the second set to attach to the body in spaces provided between the members of the first set, and the members of the second set are spaced to allow members of the first set to detach from the body without detaching the members of the second set. Also, fill stations and base stations are provided for personal pump systems.
    Type: Grant
    Filed: March 22, 2011
    Date of Patent: August 9, 2022
    Assignee: DEKA Products Limited Partnership
    Inventors: Larry B. Gray, Eric Yeaton
  • Patent number: 11406755
    Abstract: An on-body injector includes a drug reservoir with an associated temperature sensor. A piston having an associated force sensor is driven to convey a drug out of the drug reservoir during a drug delivery routine. The temperature and force sensors are electrically coupled to a controller that controls the components of the on-body injector to execute a drug delivery routine. The controller receives signals from the temperature sensor indicative of a temperature of the drug within the reservoir and from the force sensor indicative of a force experienced by the piston during the drug delivery routine. The controller analyzes the signals to determine whether the measured force is different from an expected force at the measured temperature. The controller generates an error signal when the measured force is different from the expected force at the measured temperature.
    Type: Grant
    Filed: February 19, 2021
    Date of Patent: August 9, 2022
    Assignee: Fresenius Kabi Deutschland GmbH
    Inventors: David R. Schiff, Sharon D. West, Jason Zerweck
  • Patent number: 11389198
    Abstract: A method of determining a pressure of a body cavity with a controller of a fluid management system includes determining a pressure and a volume of a cuff disposed about a collapsible bag, determining a volume of the collapsible bag based on the pressure and the volume of the cuff, and determining a pressure of the collapsible bag based on the volume of the collapsible bag. The method also includes calculating a fluid flow from the collapsible bag into a body cavity from the collapsible bag and determining a pressure of the body cavity based on the fluid flow.
    Type: Grant
    Filed: January 7, 2019
    Date of Patent: July 19, 2022
    Assignee: Covidien LP
    Inventors: Jordan A. Whisler, Nikolai D. Begg
  • Patent number: 11357916
    Abstract: A drug delivery device includes a container for storing a drug, the container having a stopper for expelling the drug; an injection drive comprising an energy source for directly or indirectly acting on the stopper to expel the drug; a sensor for detecting contact between the drug delivery device and a body of a patient; and a user interface (UI) for activating or causing the activation of the injection drive. The device is operative for drawing attention to the UI, if the sensor detects contact between the drug delivery device and the body of the patient, to thereby indicate that the injection drive is ready to be activated, which activation is the next step in the drug administration process.
    Type: Grant
    Filed: December 10, 2015
    Date of Patent: June 14, 2022
    Assignee: AMGEN INC.
    Inventors: Adam B. McCullough, Scott R. Gibson
  • Patent number: 11324885
    Abstract: An infusion device (1) for administering a medical fluid to a patient (P) comprises a pump mechanism (11) for administering a medical fluid to a patient (P) through a line set (3), a sensor device (14) for measuring a measurement value indicative of a pressure in the line set (3), and a processor device (15) configured to automatically set, in an initial phase, a threshold value (15) to a value determined based on at least a mechanical characteristic of the line set (3) and/or the pump mechanism (11) and to determine, in an operational phase, whether an occlusion condition in the line set (3) is present based on the measurement value and the threshold value (Pthres) —Herein, the processor device (15) is configured to adjust the threshold value (Pthres) if in the operational phase a pressure variation condition in the line set (3) different than an occlusion condition is detected by the processor device (15).
    Type: Grant
    Filed: October 16, 2018
    Date of Patent: May 10, 2022
    Assignee: Fresenius Vial SAS
    Inventor: Rémy Wolff
  • Patent number: 11318247
    Abstract: A peristaltic infusion pump with improved low flow performance. The pump includes a cam shaft having cams offset in an axial direction, pump fingers that engage a tube, each finger coupled to a respective cam, the fingers creating a pumping region and an occlusion region within the tube, a motor coupled to the cam shaft, a memory, and a controller. The controller implements cam rotation instructions received from the memory to cause the pump to position the fingers in the occlusion region prior to beginning an infusion therapy to deliver fluid to patient through the tube at a patient fluid delivery rate, rotate the cam shaft to transition the fingers from the occlusion region to the pumping region at a startup rate that is faster than a patient fluid delivery rate, and rotate the cam shaft at the patient fluid delivery rate in the pumping region.
    Type: Grant
    Filed: December 6, 2019
    Date of Patent: May 3, 2022
    Assignee: B Braun Medical Inc.
    Inventors: Sean Buxton, Benjamin Vespone
  • Patent number: 11306711
    Abstract: A miniature cooling system includes a base metal sheet, a flow channel layer, a piezoelectrically actuated metal sheet, a piezoelectric boundary compression layer and two piezoelectric ceramic vibrators. The flow channel layer is located on the base metal sheet and includes a first chamber, a second chamber, an inlet channel, a linking channel and an outlet channel. The inlet channel links the outside environment to the first chamber. The linking channel links the first chamber and the second chamber. The outlet channel links the second chamber to the outside environment. The piezoelectrically actuated metal sheet is located on the flow channel layer. The piezoelectric boundary compression layer is located on the piezoelectrically actuated metal sheet. The piezoelectric boundary compression layer includes two containing areas, and the two containing areas are respectively located above the first chamber and the second chamber.
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: April 19, 2022
    Assignee: CHUNG-YUAN CHRISTIAN UNIVERSITY
    Inventors: Yung Ting, Sheuan-Perng Lin, Chien-Ping Wang, Chien-Hsiang Wu, Jun-Hao Chen
  • Patent number: 11298456
    Abstract: Infusion fluid is flowed through a fluid delivery line of an infusion system. Optical signals having different wavelengths are transmitted through the fluid delivery line. The transmitted optical signals having the different wavelengths are received. At least one processor determines whether air or infusion fluid is disposed in the fluid delivery line based on the received optical signals having the different wavelengths.
    Type: Grant
    Filed: July 8, 2019
    Date of Patent: April 12, 2022
    Assignee: ICU Medical, Inc.
    Inventors: Gary David Shubinsky, Tamas Ban, Brian G. Markey
  • Patent number: 11291817
    Abstract: A medicament delivery device comprises a delivery assembly for transdermally delivering medicament to a patient and a system for providing information on the volume of medicament in the device. The system comprises a sensing unit configured to measure at least one physical parameter dependent on the volume of medicament in the device.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: April 5, 2022
    Assignee: Sanofi
    Inventors: Thomas Klemm, Dietmar Hammen
  • Patent number: 11266781
    Abstract: An electronic system (200) connectable to a medication delivery pen (4) and a needle assembly (2, 100), the electronic system (200) exchanging data regarding a medicament traveling from the medication delivery pen (4) to the needle assembly (2,100), the electronic system (200) comprising a hub (214) having a spike (216) that is configured to engage the medication delivery pen (4) and pierce a reservoir septum (6) of the medication delivery pen (4), a flow sensor (220) that is in fluid communication with the hub (214) to measure flow data of the medicament, one or more circuit boards (250, 260) electrically contacting the flow sensor (220) to process and transmit the flow data, the one or more circuit hoards (250, 260) include one or more fluid path holes (256, 264) to route a flow of medicament, and a septum (270, 284) that is configured to provide fluid communication between the flow sensor (220) and one of a plurality of needles (40, 124) of the needle assembly (2, 100) to administer the medicament to a pat
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: March 8, 2022
    Assignee: Becton, Dickinson and Company
    Inventors: Sudarsan Srinivasan, Cole Constantineau, Michel Bruehwiler, Tyson Montidoro, Jeffrey Chagnon, Mohammadreza Ramezanifard, Stefan Gisler
  • Patent number: 11264199
    Abstract: A microfluidic cell system to measure proton concentration in a fluid sample. The microfluidic cell system includes: a first microchip and a second microchip dimensioned to permit electron beam scanning of a fluid sample; a first membrane attached to the first microchip; a second membrane attached to the second microchip, the first membrane and the second membrane being disposed adjacent to one another with a space for the fluid sample therebetween, and the first membrane and the second membrane including a region of the fluid sample in which an electron beam is scanned; a first electrode patterned onto the first membrane and positioned a first distance from the region; a second electrode patterned onto the first microchip and positioned a second distance from the region, the first distance being less than the second distance; and a potentiostat in communication with the first electrode and the second electrode.
    Type: Grant
    Filed: July 2, 2020
    Date of Patent: March 1, 2022
    Assignee: UNIVERSITY OF MARYLAND, COLLEGE PARK
    Inventors: Taylor Woehl, Mei Wang
  • Patent number: 11253650
    Abstract: An electrical information device and a medicament delivery device are presented. The electrical information device includes at least one start of delivery sensor configured to detect a distal axial movement of a release member of the medicament delivery device. The release member is configured to be distally moved when an activator member of the medicament delivery device 1 is forced distally. The electrical information device also includes at least one information communication unit, which is configured to communicate information related to the medicament delivery. The electrical information device further includes at least one activation unit, which is configured to activate the at least one information communication unit based on a detected distal axial movement of the release member.
    Type: Grant
    Filed: December 15, 2016
    Date of Patent: February 22, 2022
    Assignee: SHL MEDICAL AG
    Inventors: Daniel Carlsson, Daniel Säll
  • Patent number: 11246967
    Abstract: A breast shield unit of a breast pump for expressing human breastmilk comprises a breast shield to be placed onto a mother's breast, a breastmilk collection container for receiving expressed breastmilk, an adapter for connecting the breast shield to the breastmilk collection container and a valve head. A breastmilk channel extends from the breast shield into the breastmilk collection container through the adapter and the valve head. The valve head includes a valve which closes and opens the breastmilk channel during the pumping action, wherein a fill level sensor for measuring a fill level of the breastmilk collection container is arranged in the valve head. The breast shield unit according to the invention facilitates a fill level measurement without a structural change of the breast shield and breastmilk collection container. Moreover, it facilitates data interchange with external information storage and/or information processing units.
    Type: Grant
    Filed: September 14, 2017
    Date of Patent: February 15, 2022
    Assignee: MEDELA HOLDING AG
    Inventors: Beda Weber, Martin Thüring, Mario Rigert, Armin Felber
  • Patent number: 11241530
    Abstract: A body-worn medication delivery pump having a patch form factor is provided that includes an integrated plethysmographic module that employs a photoplethysmographic multi-chip package disposed in a frame designed to maintain contact with a wearer's skin during motion, and reduces cross-talk and ingress of stray light, a controller of the pump programmed to adjust its medication delivery algorithms responsive to outputs of the plethysmographic module.
    Type: Grant
    Filed: November 23, 2020
    Date of Patent: February 8, 2022
    Assignee: AMF Medical SA
    Inventors: Pierre Fridez, Laurent Mosimann, Antoine Barraud
  • Patent number: 11241532
    Abstract: A drug delivery system having a drug delivery device and an associated sensor is provided. The sensor can be associated with a sensing site on user. The drug delivery device can be positioned over the sensor in any rotational position and can be associated with an infusion site on the user. The close positioning of the sensor and the drug delivery device allows data from the sensor to be relayed to the drug delivery device and then on to a remote control device. Further, the drug delivery device can be replaced at the end of its duration of use, which is shorter than the duration of use of the sensor, without disturbing the sensor. Subsequent drug delivery devices can then be used with the sensor while allowing each corresponding infusion site to be changed, thereby providing more efficient operation of the drug delivery system.
    Type: Grant
    Filed: August 29, 2018
    Date of Patent: February 8, 2022
    Assignee: INSULET CORPORATION
    Inventors: David Nazzaro, John D'Arco, Jason O'Connor, Ian McLaughlin
  • Patent number: 11229743
    Abstract: A medication delivery device having a lock element. The device is connectable to an electrical plug of a conduit. The device includes an external housing with an opening that ports to a plug receiving hollow within an interior volume. An electrical circuit connected to at least one of a rechargeable battery and a memory controller includes a connection element within the plug receiving hollow. The lock element travels within the plug receiving hollow when a dose delivery assembly of the device operates for forcing medication from the device. The lock element is sized and positioned to have its travel halted by abutment with the plug, when the plug is within the plug receiving hollow and electrically interfacing with the connection element, to thereby halt the dose delivery assembly from further operating for forcing medication from the device.
    Type: Grant
    Filed: November 8, 2017
    Date of Patent: January 25, 2022
    Assignee: Eli Lilly and Company
    Inventors: Roy Howard Byerly, Kimberly Ann Ringenberger
  • Patent number: 11229778
    Abstract: An intrathecal drug delivery system configured to monitor one or more physiological conditions of the patient to look for opportunities to time medicament delivery to coincide with patient activity inferring heightened cerebrospinal fluid oscillations, thereby improving dispersion of the medicament within the intrathecal space of the patient. The intrathecal drug delivery system includes an implantable medical pump, one or more physiological sensors, and an external programmer configured to program the implantable medical pump with a treatment protocol specifying at least one period of time during which a specified quantity of medicament is to be administered during which the implantable medical pump utilizes data from the one or more physiological sensors to time delivery of the medicament.
    Type: Grant
    Filed: June 18, 2019
    Date of Patent: January 25, 2022
    Assignee: Medtronic, Inc.
    Inventor: Jeffrey Bodner
  • Patent number: 11191891
    Abstract: Some embodiments of an infusion pump system may be configured to detect when at least one component of the pump system is exposed to an impact above a threshold level. In particular embodiments, the infusion pump system can be equipped with a drive system detection system configured to detect when one or more components of the drive system are damaged or inoperable.
    Type: Grant
    Filed: January 29, 2019
    Date of Patent: December 7, 2021
    Assignee: BIGFOOT BIOMEDICAL, INC.
    Inventors: Wenkang Qi, David Thrower, Tracy Brewer
  • Patent number: 11191503
    Abstract: A method for imaging a coronary arterial system of an individual includes releasing, using an actuator, pulses of a radio-opaque dye into a coronary arterial tree of the individual. The method further includes obtaining, using an image capture device, a sequence of invasive coronary x-ray angiogram images over time of the pulses of the radio-opaque dye. The method also includes tracking, using a processor, the pulses through the sequence of invasive coronary x-ray angiogram images and locating the pulses on a three dimensional (3D) structural model of the coronary arterial system to generate a three dimensional (3D) functional model of the coronary arterial system that shows a trajectory of the dye as it flows through different arterial branches.
    Type: Grant
    Filed: July 17, 2018
    Date of Patent: December 7, 2021
    Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Stephen Michael Moore, Kerry J. Halupka, Yasmin Blunck, Sergiy Zhuk
  • Patent number: 11179524
    Abstract: Disclosed is an auto-injector for administering a medicament, comprising: a housing; a cartridge receiver configured to receive a cartridge comprising a first stopper; a drive module coupled to move a plunger rod configured to move the first stopper; a resistance sensor configured to provide a resistance signal indicative of resistance against movement of the plunger rod; and a processing unit coupled to the drive module and to the resistance sensor. The processing unit being configured to: control the drive module to move the plunger rod towards the extended plunger rod position; determine present plunger rod position; receive the resistance signal; determine a cartridge parameter based on the resistance signal and the present plunger rod position; and control the drive module to adjust the movement of the plunger rod based on the cartridge parameter.
    Type: Grant
    Filed: December 29, 2016
    Date of Patent: November 23, 2021
    Assignee: Ascendis Pharma A/S
    Inventors: Per Mølgaard Pedersen, Michael Lind, Steen Jensen, Henrik Egesborg
  • Patent number: 11167074
    Abstract: Systems, apparatuses, and methods for utilizing a dressing having a single manifold fluidly coupled to at least two therapy units in a negative-pressure therapy and/or instillation therapy environment as set forth herein. In one example embodiment wherein the therapy system comprises two therapy units, apparatus and methods may be utilized for alternately applying pressure or fluids to a single tissue site to more quickly remove large amounts of fluid from the tissue site.
    Type: Grant
    Filed: January 31, 2017
    Date of Patent: November 9, 2021
    Assignee: KCl Licensing, Inc.
    Inventors: Timothy Mark Robinson, Christopher Brian Locke, James A. Luckemeyer
  • Patent number: 11166654
    Abstract: Method and device for outputting one or more signals associated with a monitored analyte level of an individual, the one or more signals including a substantially real time monitored analyte level and a rate of change information associated with the monitored analyte level, outputting a carbohydrate intake event indication, determining one or more data associated with one or more therapy information related to the monitored analyte level and the meal event indication, and outputting the determined one or more data over the outputted one or more signals associated with the monitored analyte level and the carbohydrate intake event indication are provided.
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: November 9, 2021
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Thomas A. Peyser, Marc B. Taub, R. Curtis Jennewine, Timothy Christian Dunn, Kerstin Rebrin
  • Patent number: 11167126
    Abstract: The present disclosure discusses a system and methods for a deep brain stimulation lead. More particularly, the disclosure discusses a stimulation lead that includes one or more silicon based barrier layers within a MEMS film. The silicon based barrier layers can improve device reliability and durability. The silicon based barrier layers can also improve adhesion between the layers of the MEMS film.
    Type: Grant
    Filed: August 26, 2019
    Date of Patent: November 9, 2021
    Assignee: ALEVA NEUROTHERAPEUTICS
    Inventors: André Mercanzini, Alain Jordan, Alexandre Michalis, Marc Boers, Alain Dransart
  • Patent number: 11167088
    Abstract: An injection device includes a container receiving receptacle configured for receiving a container for containing a medicinal product to be administered; a dispensing mechanism for causing the product in the container to be injected; and a RFID system associated with the container receiving receptacle capable of communicating bidirectionally with a RFID tag attached to the container and enabling the administration of the product only under given conditions. The RFID tag can be therefore read and written by the RFID system. The RFID system further includes an antenna arranged at least partially covering the RFID tag. The dispensing mechanism is triggered by a contact sensor when the device is pressed onto the animal's skin. The needle-free injection device is capable of communicating with external devices (PC, laptops, tablets, smartphones and the like).
    Type: Grant
    Filed: December 22, 2015
    Date of Patent: November 9, 2021
    Assignee: HIPRA SCIENTIFIC, S.L.U.
    Inventors: Marc Font Ventura, Maria Glòria Pujol Prat, Joan Carles Pons Moll
  • Patent number: 11163455
    Abstract: The present invention provides a measuring device (1, 11) for measuring signals (2, 12), the measuring device (1, 11) comprising a data memory (4, 14) configured to store device data (5, 15) for the measuring device (1, 11), and a data interface (6, 16) connected to the data memory (4, 14) and configured to read the device data (5, 15) from the data memory (4, 14) and output at least a part of the read device data (5, 15) to an external memory device (7, 17) in a storage mode and to read device data (5, 15) from the external memory device (7, 17) and store the read device data (5, 15) in the data memory (4, 14) in a recovery mode. The present invention further provides a corresponding method for such a measuring device (1, 11).
    Type: Grant
    Filed: July 18, 2017
    Date of Patent: November 2, 2021
    Assignee: ROHDE & SCHWARZ GMBH & CO. KG
    Inventor: Mario Guenther
  • Patent number: 11154651
    Abstract: A reduced-pressure system for delivering reduced pressure for medical purposes to a desired site and to receive fluids in one instance includes a reservoir having an interior space operable to contain the fluids. A reduced-pressure delivery conduit is placed in fluid communication with the interior space for delivering the reduced pressure to the desired site. A source conduit and a pressure sensor conduit are placed in fluid communication with the interior space. A pressure sensor is placed in fluid communication with the pressure sensor conduit. A reduced-pressure source is placed in fluid communication with the source conduit. A reduced-pressure control unit is associated with the pressure sensor and the reduced-pressure source and is operable to receive pressure data from the pressure sensor and supply data from the reduced-pressure source and to determine when a reservoir-full/blockage condition exists. Other systems and methods are presented.
    Type: Grant
    Filed: October 11, 2018
    Date of Patent: October 26, 2021
    Assignee: KCI Licensing, Inc.
    Inventors: Benjamin Andrew Pratt, Christopher Brian Locke, Aidan Marcus Tout
  • Patent number: 11129935
    Abstract: A regional anaesthesia injection apparatus comprising an injection volume determiner. The apparatus configured to determine a volume of a regional anaesthetic injection into a target tissue; an injection pressure determiner configured to determine a pressure of the injection; and a controller coupled to the injection volume determiner and to the injection pressure determiner and configured to provide an injection signal to control injection of fluid into the target tissue based on the determined pressure and the determined volume.
    Type: Grant
    Filed: September 23, 2019
    Date of Patent: September 28, 2021
    Assignee: The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust
    Inventors: Peter Jeffrey Young, Joseph Joachim Carter, Emad Eldin Fahmy Fawzy, John Edward Gibson
  • Patent number: 11116901
    Abstract: Missed meal bolus reminders or alerts require a user to access the user's pump and/or remote control to clear the reminder/alert even when the user skipped a meal such that no meal bolus was needed. CGM data can be leveraged such that the missed meal bolus alert is only triggered when glucose levels rise in response to consuming the meal within the programmed time window. Therefore, the alert is only provided when a meal is actually consumed and no bolus has been delivered. This further allows the user to be alerted sooner, i.e., as soon as glucose levels rise a predetermined amount or passed a predetermined threshold indicating consumption of a meal as opposed to only at the end of the programmed window.
    Type: Grant
    Filed: May 28, 2019
    Date of Patent: September 14, 2021
    Assignee: Tandem Diabetes Care, Inc.
    Inventor: Paul Harris
  • Patent number: 11103885
    Abstract: A sealant discharging apparatus includes a sealing gun, a movement controller, a discharge controller, a measuring instrument, and an air bubble detector. The sealing gun is configured to discharge sealant to an object. The movement controller is configured to cause the sealing gun and the object to move relatively. The discharge controller is configured to control a discharge amount of the sealant discharged from the sealing gun. The measuring instrument is configured to measure a distance to a sealant pool that has been discharged from the sealing gun and yet to be used to seal the object. The air bubble detector is configured detect mixture of an air bubble in the sealant discharged from the sealing gun, on a basis of a result of measurement by the measuring instrument.
    Type: Grant
    Filed: October 1, 2019
    Date of Patent: August 31, 2021
    Assignee: SUBARU CORPORATION
    Inventor: Yohei Matsumoto
  • Patent number: 11097051
    Abstract: A method for providing blood glucose data is provided. In response to a suspension of a continuous basal insulin delivery, by an insulin delivery pump, the method identifies a condition indicating continuing hypoglycemia that continues when basal insulin delivery is suspended; and performs an action, by the insulin delivery pump, based on identifying the condition.
    Type: Grant
    Filed: January 19, 2017
    Date of Patent: August 24, 2021
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Di Wu, Rebecca K. Gottlieb, Benyamin Grosman, Anirban Roy, Neha J. Parikh, Ohad Cohen
  • Patent number: 11089971
    Abstract: Apparatus and methods for the measurement, control, or both, of thermodilution injectate flow for calculation of transpulmonary thermodilution parameters. An injectate delivery system includes a syringe for holding an injectate and a conduit configured at one end to be connected to a catheter. A flow measurement device is interposed in the conduit to generate a signal for determining the flow rate of the fluid from the syringe to the catheter. A processor receives the signal from the flow measurement device and calculates the injectate volume to be used as input for calculating a transpulmonary thermodilution parameter such as cardiac output. A GUI is provided to direct a user on whether the injection rate is too fast or too slow. Rather than measuring or calculating flow rate, a system may include a constant flow valve to provide a constant flow rate from the syringe.
    Type: Grant
    Filed: October 21, 2015
    Date of Patent: August 17, 2021
    Assignee: Edwards Lifesciences Corporation
    Inventors: Alexander H. Siemons, Wei-Jiun Liu
  • Patent number: 11094409
    Abstract: According to one embodiment, a system includes a medical device configured to provide a function to a user, communicate via a wireless communication channel with one or more other devices, and send a signal to shift a medical device application from a locked state to an unlocked state. The system also includes a computing device having wireless communication channels and a processor and logic integrated with and/or executable by the processor. The logic is configured to cause the computing device to communicate with the medical device, execute the medical device application, and shift from the locked state to the unlocked state in response to receiving the signal from the medical device. Core functionality of the medical device application is disabled when the medical device application is in the locked state, and some functionality applicable to the medical device is enabled when the medical device application is in the unlocked state.
    Type: Grant
    Filed: January 19, 2016
    Date of Patent: August 17, 2021
    Assignee: Novartis AG
    Inventors: Dominik Ziegler, Manfred Mueller
  • Patent number: 11089967
    Abstract: A fluid controller includes a piezoelectric pump, a valve, and a cuff. The valve includes a first valve housing, a diaphragm, and a second valve housing. The second valve housing has a second air hole, a third air hole, and a first valve seat. The second air hole connects to the internal space of the cuff. The third air hole connects to the outside of the fluid controller. The first valve seat is formed around the third air hole. Together, the second valve housing and the diaphragm form a first flow passage. The first flow passage connects the second air hole and the third air hole to each other. The second valve housing has a protruded portion protruding toward the diaphragm and providing a portion of the first flow passage. The shortest distance between the protruded portion and the diaphragm is less than the diameter of the third air hole.
    Type: Grant
    Filed: October 10, 2018
    Date of Patent: August 17, 2021
    Assignee: MURATA MANUFACTURING CO., LTD.
    Inventor: Kenichiro Kawamura
  • Patent number: 11075012
    Abstract: Configuration output for use in configuring a patient care device for administration of a therapy to a patient. The configuration output may include at least one code. The code may be used in the verification and/or indication of at least one configuration data component used in the configuration of the patient care device to be used to administer a therapy to a patient. Additionally, a check code for validation of the entry of the code and/or check code may be provided.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: July 27, 2021
    Assignee: Baxter Corporation Englewood
    Inventor: Dennis I Schneider
  • Patent number: 11071813
    Abstract: An extracorporeal blood heating and cooling system that is connectable to an oxygenator of a cardiopulmonary bypass system, the heating and cooling system comprising: a heater-cooler unit; a coolant flow circuit that is configured to pass coolant through the heater-cooler unit and the oxygenator; and a cardioplegia coolant circuit that is configured to pass coolant through the heater-cooler unit and a cardioplegia heat exchanger; wherein when the heating and cooling system is in a purging mode, the coolant flow circuit and the cardioplegia coolant circuit contain temperature-controlled coolant having a trisodium phosphate concentration of about 1-35 millimole/liter; wherein when the heating and cooling system is in a coolant mode, the coolant flow circuit and the cardioplegia coolant circuit contain temperature-controlled coolant having a trisodium phosphate concentration of about 1-10 millimole/liter; and wherein when the heating and cooling system is in the coolant mode or the purging mode, a first and seco
    Type: Grant
    Filed: November 2, 2018
    Date of Patent: July 27, 2021
    Assignee: MAQUET CARDIOPULMONARY GMBH
    Inventor: Herwig Ernst Reichl
  • Patent number: 11069438
    Abstract: A medical device is disclosed. The medical device includes an RFID reader for receiving information from at least one RFID transponder. The medical device also includes a memory for storing a database and at least one processor for processing information. Also, a remote controller for a medical device is disclosed. The remote controller includes an information receiver for receiving information related to food. The infusion device also includes a memory for storing a database and at least one processor for processing information. A method for use in a medical device is also disclosed. The method includes receiving information from an RFID transponder related to food. Also, the processing the information by comparing the information to a database is included in the method. The method also includes determining the acceptability of the food and providing information related to acceptability to the user.
    Type: Grant
    Filed: January 31, 2020
    Date of Patent: July 20, 2021
    Assignee: DEKA Products Limited Partnership
    Inventor: Dean Kamen
  • Patent number: 11033681
    Abstract: Disclosed is a medical device for pumping fluid through a conduit, the pump including: one or more sensors to detect a parameter associated with the fluid; a circuit to (a) receive from the sensor a first signal indicative of one or more characteristics associated with the fluid; and (b) to determine if an occlusion is indicated based on a signal analysis of the first signal.
    Type: Grant
    Filed: May 27, 2018
    Date of Patent: June 15, 2021
    Assignee: Q-CORE MEDICAL LTD.
    Inventors: Boaz Eitan, Nimrod Schweitzer, Dafna Kesselman, Nora Lisman, Andrei Yosef
  • Patent number: 11027142
    Abstract: A system employing an ECG monitor (40) and a defibrillation advisory controller (20). In operation, the ECG monitor (40) monitors a cardiac rhythm of a patient, and the defibrillation advisory controller (20) generates a defibrillation advisory based on a cardiac rhythm status and a metabolic cardiac status of the patient, and optionally further based on an electrical cardiac status of the patient. The controller (20) derives the cardiac rhythm status as monitored by ECG monitor (40), and the optional electrical cardiac status inclusive of the cardiac rhythm monitored by the ECG monitor (40), and derives the metabolic cardiac status exclusive of the cardiac rhythm monitored by the ECG monitor (40). The controller (20) may compute or receive metabolic cardiac data indicative of the metabolic cardiac status (e.g.
    Type: Grant
    Filed: March 29, 2016
    Date of Patent: June 8, 2021
    Assignee: Koninklijke Philips N.V.
    Inventor: Michael Nakagawa
  • Patent number: 11006829
    Abstract: Systems, devices, and methods are disclosed for wireless communication of analyte data. One such method includes, during a first interval, establishing a first connection between an analyte sensor system and a display device. During the first connection, the method includes exchanging information related to authentication between the analyte sensor system and the display device. The method includes making a determination regarding whether authentication was performed during the first interval. During a second interval, the method may include establishing a second connection between the analyte sensor system and the display device for transmission of an encrypted analyte value, and bypassing the exchanging of information related to authentication performed during the first connection.
    Type: Grant
    Filed: January 15, 2021
    Date of Patent: May 18, 2021
    Assignee: DexCom, Inc.
    Inventors: Aditya Mandapaka, Jorge Valdes, Jeffrey R. Wedekind, Eric Cohen, Douglas William Burnette, Francis William Pascual, Hari Hampapuram, Mark Dervaes, Michael Robert Mensinger